| NCT03398161 |
Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT03398161 |
Recruiting |
M.D. Anderson Cancer Center |
2020-09-30 |
| NCT03385226 |
A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) |
https://ClinicalTrials.gov/show/NCT03385226 |
Recruiting |
University College, London |
2022-01-31 |
| NCT03923010 |
A Study of Itraconazole in the Management of Superficial Fungal Infections in India |
https://ClinicalTrials.gov/show/NCT03923010 |
Recruiting |
Janssen Research & Development, LLC |
2020-07-16 |
| NCT03390374 |
Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants |
https://ClinicalTrials.gov/show/NCT03390374 |
Completed |
Dr Cipto Mangunkusumo General Hospital |
2012-11-30 |
| NCT03380026 |
Mechlorethamine Induced Contact Dermatitis Avoidance Study |
https://ClinicalTrials.gov/show/NCT03380026 |
Recruiting |
Rochester Skin Lymphoma Medical Group, PLLC |
2019-12-13 |
| NCT02811783 |
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL |
https://ClinicalTrials.gov/show/NCT02811783 |
Recruiting |
Elorac, Inc. |
2022-06-30 |
| NCT03357224 |
PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) |
https://ClinicalTrials.gov/show/NCT03357224 |
Recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2021-09-30 |
| NCT03336502 |
Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120) |
https://ClinicalTrials.gov/show/NCT03336502 |
Completed |
Merck Sharp & Dohme Corp. |
2018-11-26 |
| NCT03318159 |
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients |
https://ClinicalTrials.gov/show/NCT03318159 |
Recruiting |
Seoul National University Hospital |
2019-06-30 |
| NCT03278782 |
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin |
https://ClinicalTrials.gov/show/NCT03278782 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT01805037 |
Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas |
https://ClinicalTrials.gov/show/NCT01805037 |
Active, not recruiting |
Northwestern University |
2021-01-31 |
| NCT03059992 |
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment |
https://ClinicalTrials.gov/show/NCT03059992 |
Recruiting |
Scynexis, Inc. |
2021-09-30 |
| NCT03063632 |
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma |
https://ClinicalTrials.gov/show/NCT03063632 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-05-01 |
| NCT03017820 |
VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, or T-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03017820 |
Recruiting |
Mayo Clinic |
2021-01-15 |
| NCT03011814 |
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03011814 |
Recruiting |
City of Hope Medical Center |
2023-03-08 |
| NCT03005353 |
Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories. |
https://ClinicalTrials.gov/show/NCT03005353 |
Completed |
Assiut University |
2019-10-31 |
| NCT02978625 |
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers |
https://ClinicalTrials.gov/show/NCT02978625 |
Recruiting |
National Cancer Institute (NCI) |
2021-06-01 |
| NCT02971007 |
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) |
https://ClinicalTrials.gov/show/NCT02971007 |
Completed |
Matinas BioPharma Nanotechnologies, Inc. |
2017-05-31 |
| NCT02968134 |
Single Dose Population Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT02968134 |
Completed |
Royal Brisbane and Women’s Hospital |
2017-05-21 |
| NCT02957929 |
Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally |
https://ClinicalTrials.gov/show/NCT02957929 |
Completed |
Amplyx Pharmaceuticals |
2017-04-20 |
| NCT02956499 |
Safety, Tolerability and Pharmacokinetics of APX001 Administered Intravenously |
https://ClinicalTrials.gov/show/NCT02956499 |
Completed |
Amplyx Pharmaceuticals |
2017-07-31 |
| NCT02912156 |
Pharmacokinetics of Two Different Formulation of Voriconazole |
https://ClinicalTrials.gov/show/NCT02912156 |
Completed |
Yung Shin Pharm. Ind. Co., Ltd. |
2016-07-31 |
| NCT02805946 |
Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT02805946 |
Completed |
Radboud University |
2019-07-26 |
| NCT02734862 |
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension |
https://ClinicalTrials.gov/show/NCT02734862 |
Completed |
Cidara Therapeutics Inc. |
2019-06-30 |
| NCT02733432 |
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections |
https://ClinicalTrials.gov/show/NCT02733432 |
Completed |
Cidara Therapeutics Inc. |
2016-11-23 |
| NCT02631954 |
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02631954 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-10-31 |
| NCT02582177 |
Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis |
https://ClinicalTrials.gov/show/NCT02582177 |
Recruiting |
Ache Laboratorios Farmaceuticos S.A. |
2019-12-13 |
| NCT02542124 |
NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) |
https://ClinicalTrials.gov/show/NCT02542124 |
Active, not recruiting |
Neumedicines Inc. |
2019-02-28 |
| NCT02520791 |
Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT02520791 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT02493738 |
A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT02493738 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2015-10-31 |
| NCT02387983 |
Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) |
https://ClinicalTrials.gov/show/NCT02387983 |
Completed |
Merck Sharp & Dohme Corp. |
2016-05-02 |
| NCT02343627 |
Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail |
https://ClinicalTrials.gov/show/NCT02343627 |
Completed |
Taro Pharmaceuticals USA |
2016-01-31 |
| NCT02341209 |
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT02341209 |
Recruiting |
Rochester General Hospital |
2020-02-06 |
| NCT02244606 |
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT02244606 |
Completed |
Scynexis, Inc. |
2016-06-30 |
| NCT02243579 |
Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome |
https://ClinicalTrials.gov/show/NCT02243579 |
Completed |
National Cancer Institute (NCI) |
2018-01-04 |
| NCT02232516 |
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT02232516 |
Recruiting |
Northwestern University |
2022-07-31 |
| NCT02227797 |
MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients |
https://ClinicalTrials.gov/show/NCT02227797 |
Completed |
Masonic Cancer Center, University of Minnesota |
2017-09-08 |
| NCT01578499 |
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician’s Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) |
https://ClinicalTrials.gov/show/NCT01578499 |
Completed |
Takeda |
2016-05-31 |
| NCT04039880 |
Absorption, Metabolism and Excretion of 14C-olorofim in Man |
https://ClinicalTrials.gov/show/NCT04039880 |
Completed |
F2G Ltd. |
2019-09-30 |
| NCT02180165 |
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) |
https://ClinicalTrials.gov/show/NCT02180165 |
Completed |
Merck Sharp & Dohme Corp. |
2018-01-24 |
| NCT02172768 |
Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease |
https://ClinicalTrials.gov/show/NCT02172768 |
Completed |
Radboud University |
2016-06-30 |
| NCT02168140 |
CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT02168140 |
Active, not recruiting |
Wake Forest University Health Sciences |
2019-04-18 |
| NCT02154178 |
Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE) |
https://ClinicalTrials.gov/show/NCT02154178 |
Completed |
University Hospital, Lille |
2016-10-31 |
| NCT02079298 |
Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants |
https://ClinicalTrials.gov/show/NCT02079298 |
Completed |
Karolinska Institutet |
2015-09-30 |
| NCT01318148 |
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis |
https://ClinicalTrials.gov/show/NCT01318148 |
Completed |
Wuerzburg University Hospital |
2013-09-30 |
| NCT01307930 |
Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations |
https://ClinicalTrials.gov/show/NCT01307930 |
Completed |
Texas Tech University Health Sciences Center |
2012-11-30 |
| NCT01307579 |
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01307579 |
Active, not recruiting |
Children’s Oncology Group |
2018-06-30 |
| NCT01303549 |
Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01303549 |
Completed |
Fundacion SEIMC-GESIDA |
2014-05-31 |
| NCT01273766 |
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01273766 |
Completed |
Wake Forest University Health Sciences |
2012-03-31 |
| NCT01288378 |
Empirical Versus Preemptive Antifungal Therapy |
https://ClinicalTrials.gov/show/NCT01288378 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2019-04-04 |
| NCT03810196 |
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT |
https://ClinicalTrials.gov/show/NCT03810196 |
Recruiting |
Children’s Hospital of Philadelphia |
2024-01-31 |
| NCT01968395 |
Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure |
https://ClinicalTrials.gov/show/NCT01968395 |
Completed |
Erasme University Hospital |
2014-08-31 |
| NCT01959477 |
Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01959477 |
Completed |
Case Comprehensive Cancer Center |
2015-01-31 |
| NCT01916057 |
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis |
https://ClinicalTrials.gov/show/NCT01916057 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-06-01 |
| NCT01888458 |
Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD) |
https://ClinicalTrials.gov/show/NCT01888458 |
Completed |
Nantes University Hospital |
2016-04-30 |
| NCT01839916 |
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01839916 |
Completed |
University of Chicago |
2018-08-31 |
| NCT01823289 |
An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections |
https://ClinicalTrials.gov/show/NCT01823289 |
Completed |
Xian-Janssen Pharmaceutical Ltd. |
2008-12-31 |
| NCT01800838 |
Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01800838 |
Completed |
Case Comprehensive Cancer Center |
2014-09-30 |
| NCT01782131 |
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) |
https://ClinicalTrials.gov/show/NCT01782131 |
Completed |
Merck Sharp & Dohme Corp. |
2019-07-10 |
| NCT01777763 |
Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615) |
https://ClinicalTrials.gov/show/NCT01777763 |
Completed |
Merck Sharp & Dohme Corp. |
2012-02-29 |
| NCT01772212 |
Bioequivalence Study for Terbinafine 250 mg |
https://ClinicalTrials.gov/show/NCT01772212 |
Completed |
GlaxoSmithKline |
2011-03-15 |
| NCT01748721 |
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT01748721 |
Completed |
Morphotek |
2015-05-31 |
| NCT01724229 |
Clinical Case Series Evaluating Skin Wellness System |
https://ClinicalTrials.gov/show/NCT01724229 |
Completed |
GM Associates |
2013-06-30 |
| NCT01686594 |
PUVA Maintenance Therapy in Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT01686594 |
Completed |
Medical University of Graz |
2018-07-02 |
| NCT01678443 |
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies |
https://ClinicalTrials.gov/show/NCT01678443 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2011-04-11 |
| NCT01658319 |
Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01658319 |
Completed |
Case Comprehensive Cancer Center |
2015-02-28 |
| NCT01657201 |
Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend) |
https://ClinicalTrials.gov/show/NCT01657201 |
Completed |
Samyang Biopharmaceuticals Corporation |
2012-11-30 |
| NCT01590732 |
Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01590732 |
Completed |
M.D. Anderson Cancer Center |
2018-05-02 |
| NCT01588015 |
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01588015 |
Active, not recruiting |
City of Hope Medical Center |
2021-11-30 |
| NCT01576653 |
Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL |
https://ClinicalTrials.gov/show/NCT01576653 |
Recruiting |
Medical University of Graz |
2019-06-30 |
| NCT01567709 |
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01567709 |
Completed |
National Cancer Institute (NCI) |
2018-03-29 |
| NCT01529827 |
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01529827 |
Completed |
Roswell Park Cancer Institute |
2015-05-28 |
| NCT01523223 |
Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies |
https://ClinicalTrials.gov/show/NCT01523223 |
Completed |
Stanford University |
2016-09-30 |
| NCT01503515 |
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01503515 |
Active, not recruiting |
Children’s Oncology Group |
2019-12-31 |
| NCT01484015 |
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT01484015 |
Completed |
Wake Forest University Health Sciences |
2012-06-30 |
| NCT01427881 |
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01427881 |
Completed |
Fred Hutchinson Cancer Research Center |
2014-06-30 |
| NCT03602157 |
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL |
https://ClinicalTrials.gov/show/NCT03602157 |
Recruiting |
UNC Lineberger Comprehensive Cancer Center |
2026-09-30 |
| NCT01416025 |
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing |
https://ClinicalTrials.gov/show/NCT01416025 |
Completed |
Johns Hopkins University |
2014-12-31 |
| NCT03159364 |
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections |
https://ClinicalTrials.gov/show/NCT03159364 |
Recruiting |
Shenzhen Geno-Immune Medical Institute |
2020-07-31 |
| NCT01396070 |
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level |
https://ClinicalTrials.gov/show/NCT01396070 |
Completed |
Stanford University |
2015-04-30 |
| NCT01384513 |
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01384513 |
Recruiting |
Thomas Jefferson University |
2020-12-31 |
| NCT01371656 |
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01371656 |
Completed |
Children’s Oncology Group |
2017-06-30 |
| NCT01352520 |
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) |
https://ClinicalTrials.gov/show/NCT01352520 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-01-31 |
| NCT01326702 |
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors |
https://ClinicalTrials.gov/show/NCT01326702 |
Completed |
National Cancer Institute (NCI) |
2015-04-30 |
| NCT00353158 |
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity |
https://ClinicalTrials.gov/show/NCT00353158 |
Completed |
National Institutes of Health Clinical Center (CC) |
2011-09-20 |
| NCT04368559 |
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation |
https://ClinicalTrials.gov/show/NCT04368559 |
Recruiting |
Cidara Therapeutics Inc. |
2022-03-31 |
| NCT04307082 |
ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT04307082 |
Active, not recruiting |
Scynexis, Inc. |
2020-05-29 |
| NCT04273178 |
Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT04273178 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2022-01-15 |
| NCT04265521 |
Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet |
https://ClinicalTrials.gov/show/NCT04265521 |
Recruiting |
Biocool AB |
2020-06-25 |
| NCT04240886 |
An Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus Species or Rare Molds |
https://ClinicalTrials.gov/show/NCT04240886 |
Recruiting |
Amplyx Pharmaceuticals |
2021-07-31 |
| NCT04238884 |
Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy |
https://ClinicalTrials.gov/show/NCT04238884 |
Recruiting |
Instituto de Investigación Hospital Universitario La Paz |
2020-01-18 |
| NCT04256018 |
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome |
https://ClinicalTrials.gov/show/NCT04256018 |
Recruiting |
Stanford University |
2022-02-28 |
| NCT04185220 |
Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome |
https://ClinicalTrials.gov/show/NCT04185220 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-03-01 |
| NCT02822586 |
TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome |
https://ClinicalTrials.gov/show/NCT02822586 |
Completed |
Virginia Commonwealth University |
2019-04-29 |
| NCT04166669 |
A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 |
https://ClinicalTrials.gov/show/NCT04166669 |
Completed |
Amplyx Pharmaceuticals |
2020-03-03 |
| NCT04157465 |
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients |
https://ClinicalTrials.gov/show/NCT04157465 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2020-12-31 |
| NCT04122560 |
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration |
https://ClinicalTrials.gov/show/NCT04122560 |
Recruiting |
Radboud University |
2020-08-01 |
| NCT04101331 |
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT04101331 |
Recruiting |
Affimed GmbH |
2022-04-30 |
| NCT03857399 |
Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin |
https://ClinicalTrials.gov/show/NCT03857399 |
Recruiting |
Cttq |
2019-09-30 |
| NCT04035187 |
Itraconazole Oral Absorption |
https://ClinicalTrials.gov/show/NCT04035187 |
Recruiting |
University of Maryland, Baltimore |
2020-09-01 |
| NCT03941951 |
Study to Optimize the Use of New Antibiotics |
https://ClinicalTrials.gov/show/NCT03941951 |
Recruiting |
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
2020-12-31 |
| NCT03905135 |
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies |
https://ClinicalTrials.gov/show/NCT03905135 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-03-01 |
| NCT03902184 |
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT03902184 |
Recruiting |
Innate Pharma |
2022-03-01 |
| NCT03837457 |
PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study |
https://ClinicalTrials.gov/show/NCT03837457 |
Enrolling by invitation |
miRagen Therapeutics, Inc. |
2021-12-31 |
| NCT03828773 |
PTX3-targeted Antifungal Prophylaxis |
https://ClinicalTrials.gov/show/NCT03828773 |
Recruiting |
Centre Hospitalier Universitaire Vaudois |
2022-07-31 |
| NCT03814343 |
Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis |
https://ClinicalTrials.gov/show/NCT03814343 |
Recruiting |
Mahidol University |
2020-01-15 |
| NCT03760276 |
A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen |
https://ClinicalTrials.gov/show/NCT03760276 |
Completed |
Seoul National University Hospital |
2018-10-28 |
| NCT03717623 |
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants |
https://ClinicalTrials.gov/show/NCT03717623 |
Recruiting |
Melbourne Health |
2020-06-30 |
| NCT03713320 |
SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT03713320 |
Active, not recruiting |
miRagen Therapeutics, Inc. |
2021-04-30 |
| NCT03695471 |
Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT03695471 |
Recruiting |
Mayo Clinic |
2022-10-11 |
| NCT03598998 |
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas |
https://ClinicalTrials.gov/show/NCT03598998 |
Recruiting |
City of Hope Medical Center |
2021-04-27 |
| NCT03587844 |
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients |
https://ClinicalTrials.gov/show/NCT03587844 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-07-31 |
| NCT03583164 |
Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options |
https://ClinicalTrials.gov/show/NCT03583164 |
Recruiting |
F2G Ltd. |
2020-12-31 |
| NCT03577509 |
Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China |
https://ClinicalTrials.gov/show/NCT03577509 |
Completed |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2018-09-14 |
| NCT03572049 |
Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole |
https://ClinicalTrials.gov/show/NCT03572049 |
Recruiting |
University of Alabama at Birmingham |
2020-05-31 |
| NCT03471988 |
Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis |
https://ClinicalTrials.gov/show/NCT03471988 |
Recruiting |
Asahi Kasei Pharma Corporation |
2021-12-31 |
| NCT03454945 |
Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT03454945 |
Recruiting |
Cairo University |
2019-04-01 |
| NCT03434704 |
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole |
https://ClinicalTrials.gov/show/NCT03434704 |
Recruiting |
IRCCS San Raffaele |
2020-03-15 |
| NCT01259713 |
Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01259713 |
Completed |
Gilead Sciences |
2013-12-31 |
| NCT01258998 |
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma |
https://ClinicalTrials.gov/show/NCT01258998 |
Completed |
National Cancer Institute (NCI) |
2014-07-31 |
| NCT01254578 |
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT01254578 |
Completed |
National Cancer Institute (NCI) |
2012-11-09 |
| NCT01233921 |
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT01233921 |
Completed |
Fred Hutchinson Cancer Research Center |
2012-07-31 |
| NCT01232504 |
Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT |
https://ClinicalTrials.gov/show/NCT01232504 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2013-03-31 |
| NCT01231919 |
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia |
https://ClinicalTrials.gov/show/NCT01231919 |
Completed |
National Cancer Institute (NCI) |
2013-04-30 |
| NCT01261247 |
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01261247 |
Active, not recruiting |
Mayo Clinic |
2016-05-09 |
| NCT01200355 |
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01200355 |
Completed |
Memorial Sloan Kettering Cancer Center |
2017-04-20 |
| NCT01198236 |
Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection |
https://ClinicalTrials.gov/show/NCT01198236 |
Completed |
Zhejiang University |
2010-09-30 |
| NCT01177371 |
High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01177371 |
Completed |
Case Comprehensive Cancer Center |
2000-02-29 |
| NCT01169402 |
Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO) |
https://ClinicalTrials.gov/show/NCT01169402 |
Completed |
Duke University |
2013-02-20 |
| NCT01158274 |
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT01158274 |
Completed |
National Cancer Institute (NCI) |
2012-08-31 |
| NCT01134341 |
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01134341 |
Completed |
Acrotech Biopharma LLC |
2015-08-31 |
| NCT01129193 |
AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma |
https://ClinicalTrials.gov/show/NCT01129193 |
Completed |
Ohio State University Comprehensive Cancer Center |
2017-01-07 |
| NCT01129180 |
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT01129180 |
Completed |
Ohio State University Comprehensive Cancer Center |
2012-05-31 |
| NCT01122368 |
A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects |
https://ClinicalTrials.gov/show/NCT01122368 |
Completed |
Astellas Pharma Inc |
2011-12-15 |
| NCT01110135 |
Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT01110135 |
Completed |
University of Washington |
2013-11-30 |
| NCT01093586 |
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01093586 |
Completed |
Case Comprehensive Cancer Center |
2015-12-31 |
| NCT01075321 |
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT01075321 |
Active, not recruiting |
Mayo Clinic |
2015-02-28 |
| NCT01073267 |
Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT01073267 |
Completed |
M.D. Anderson Cancer Center |
2014-12-31 |
| NCT01062165 |
Effect of Weight and/or Obesity on Caspofungin Drug Concentrations |
https://ClinicalTrials.gov/show/NCT01062165 |
Completed |
Texas Tech University Health Sciences Center |
2010-12-31 |
| NCT01058174 |
Liver Transplant European Study Into the Prevention of Fungal Infection |
https://ClinicalTrials.gov/show/NCT01058174 |
Completed |
Astellas Pharma Inc |
2012-05-03 |
| NCT01053494 |
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer |
https://ClinicalTrials.gov/show/NCT01053494 |
Completed |
Wake Forest University Health Sciences |
2012-02-29 |
| NCT00997035 |
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo |
https://ClinicalTrials.gov/show/NCT00997035 |
Completed |
University of California, San Francisco |
2016-01-31 |
| NCT00996736 |
Mycotic Ulcer Treatment Trial I |
https://ClinicalTrials.gov/show/NCT00996736 |
Completed |
University of California, San Francisco |
2012-07-31 |
| NCT00961220 |
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT00961220 |
Completed |
National Cancer Institute (NCI) |
2012-04-08 |
| NCT00936117 |
Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia |
https://ClinicalTrials.gov/show/NCT00936117 |
Completed |
M.D. Anderson Cancer Center |
2013-09-30 |
| NCT00918333 |
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00918333 |
Completed |
Mayo Clinic |
2015-12-01 |
| NCT00077155 |
Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00077155 |
Completed |
National Cancer Institute (NCI) |
2010-06-30 |
| NCT00904995 |
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis |
https://ClinicalTrials.gov/show/NCT00904995 |
Completed |
M.D. Anderson Cancer Center |
2010-07-31 |
| NCT00896493 |
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT00896493 |
Active, not recruiting |
Stanford University |
2022-12-31 |
| NCT00893555 |
Pharmacologic Optimization of Voriconazole |
https://ClinicalTrials.gov/show/NCT00893555 |
Completed |
University Medical Center Groningen |
2016-11-30 |
| NCT00890747 |
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT00890747 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00890708 |
Therapeutic Drug Monitoring of Voriconazole |
https://ClinicalTrials.gov/show/NCT00890708 |
Completed |
Seoul National University Hospital |
2011-12-31 |
| NCT00856388 |
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders |
https://ClinicalTrials.gov/show/NCT00856388 |
Completed |
Roswell Park Cancer Institute |
2012-08-09 |
| NCT00842504 |
Alternate Day Micafungin: A PK Study in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT00842504 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2009-12-31 |
| NCT00841971 |
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00841971 |
Completed |
University of Pittsburgh |
2013-07-31 |
| NCT02652715 |
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT02652715 |
Completed |
Mayo Clinic |
2018-12-21 |
| NCT02851680 |
Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia. |
https://ClinicalTrials.gov/show/NCT02851680 |
Completed |
Centre Hospitalier Universitaire Dijon |
2015-05-31 |
| NCT01383993 |
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection |
https://ClinicalTrials.gov/show/NCT01383993 |
Completed |
Pfizer |
2013-05-31 |
| NCT01075984 |
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) |
https://ClinicalTrials.gov/show/NCT01075984 |
Completed |
Merck Sharp & Dohme Corp. |
2012-11-20 |
| NCT01760655 |
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01760655 |
Recruiting |
Thomas Jefferson University |
2021-03-31 |
| NCT00811928 |
Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00811928 |
Completed |
Merck Sharp & Dohme Corp. |
2010-05-31 |
| NCT00811642 |
Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551) |
https://ClinicalTrials.gov/show/NCT00811642 |
Completed |
Merck Sharp & Dohme Corp. |
2010-03-31 |
| NCT03731169 |
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels |
https://ClinicalTrials.gov/show/NCT03731169 |
Recruiting |
University Health Network, Toronto |
2019-06-30 |
| NCT03281811 |
Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT03281811 |
Active, not recruiting |
Mayo Clinic |
2020-02-25 |
| NCT02580552 |
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL |
https://ClinicalTrials.gov/show/NCT02580552 |
Active, not recruiting |
miRagen Therapeutics, Inc. |
2020-12-31 |
| NCT03667690 |
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT03667690 |
Recruiting |
Cidara Therapeutics Inc. |
2020-09-30 |
| NCT02358499 |
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children |
https://ClinicalTrials.gov/show/NCT02358499 |
Completed |
Children’s Mercy Hospital Kansas City |
2018-12-31 |
| NCT01419678 |
Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01419678 |
Completed |
University of Pittsburgh |
2014-12-31 |
| NCT00936910 |
Antifungal Locks to Treat Fungal-related Central Line Infections |
https://ClinicalTrials.gov/show/NCT00936910 |
Completed |
University of Pittsburgh |
2010-08-31 |
| NCT02953301 |
Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) |
https://ClinicalTrials.gov/show/NCT02953301 |
Recruiting |
4SC AG |
2022-01-31 |
| NCT00794703 |
A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections |
https://ClinicalTrials.gov/show/NCT00794703 |
Completed |
Astellas Pharma Inc |
2009-11-30 |
| NCT00784368 |
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection |
https://ClinicalTrials.gov/show/NCT00784368 |
Completed |
Janssen Pharmaceutical K.K. |
2009-04-30 |
| NCT00769288 |
FAU in Treating Patients With Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00769288 |
Completed |
National Cancer Institute (NCI) |
2013-12-31 |
| NCT00750737 |
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) |
https://ClinicalTrials.gov/show/NCT00750737 |
Completed |
M.D. Anderson Cancer Center |
2012-06-30 |
| NCT00748319 |
Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT00748319 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2011-11-30 |
| NCT00740389 |
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. |
https://ClinicalTrials.gov/show/NCT00740389 |
Completed |
Tibotec Pharmaceuticals, Ireland |
2009-01-31 |
| NCT00739934 |
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection |
https://ClinicalTrials.gov/show/NCT00739934 |
Completed |
Pfizer |
2009-10-31 |
| NCT00734500 |
Anidulafungin PK in Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT00734500 |
Completed |
Duke University |
2010-06-30 |
| NCT00717860 |
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00717860 |
Completed |
Merck Sharp & Dohme Corp. |
2010-07-31 |
| NCT00686543 |
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) |
https://ClinicalTrials.gov/show/NCT00686543 |
Completed |
Merck Sharp & Dohme Corp. |
2009-04-30 |
| NCT00647907 |
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections |
https://ClinicalTrials.gov/show/NCT00647907 |
Completed |
Pfizer |
NA |
| NCT00635648 |
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) |
https://ClinicalTrials.gov/show/NCT00635648 |
Completed |
Merck Sharp & Dohme Corp. |
2011-05-31 |
| NCT00634049 |
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi |
https://ClinicalTrials.gov/show/NCT00634049 |
Completed |
Astellas Pharma Inc |
2014-01-03 |
| NCT00611208 |
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) |
https://ClinicalTrials.gov/show/NCT00611208 |
Completed |
Angimmune LLC |
2015-02-28 |
| NCT00608361 |
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00608361 |
Completed |
National Cancer Institute (NCI) |
2014-08-31 |
| NCT00606268 |
A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00606268 |
Completed |
Astellas Pharma Inc |
2009-03-31 |
| NCT00601718 |
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma |
https://ClinicalTrials.gov/show/NCT00601718 |
Completed |
University of Washington |
2010-06-30 |
| NCT00550732 |
A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) |
https://ClinicalTrials.gov/show/NCT00550732 |
Completed |
Merck Sharp & Dohme Corp. |
2012-11-30 |
| NCT00548080 |
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) |
https://ClinicalTrials.gov/show/NCT00548080 |
Completed |
Merck Sharp & Dohme Corp. |
2006-11-30 |
| NCT00535470 |
An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT00535470 |
Completed |
Yaupon Therapeutics |
2011-03-31 |
| NCT00509938 |
Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00509938 |
Completed |
AM-Pharma |
2006-11-30 |
| NCT00499811 |
Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT00499811 |
Completed |
National Cancer Institute (NCI) |
2011-08-31 |
| NCT00489203 |
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00489203 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-11-30 |
| NCT00466921 |
Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome |
https://ClinicalTrials.gov/show/NCT00466921 |
Active, not recruiting |
Northwestern University |
2020-02-29 |
| NCT00458731 |
Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma |
https://ClinicalTrials.gov/show/NCT00458731 |
Completed |
National Cancer Institute (NCI) |
2013-12-31 |
| NCT00418951 |
Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT00418951 |
Completed |
M.D. Anderson Cancer Center |
2009-10-31 |
| NCT00413218 |
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections |
https://ClinicalTrials.gov/show/NCT00413218 |
Completed |
Astellas Pharma Inc |
2015-03-03 |
| NCT00412893 |
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00412893 |
Completed |
Astellas Pharma Inc |
2013-03-28 |
| NCT00386802 |
Antifungal Use in Oncohematological Neutropenic Patients |
https://ClinicalTrials.gov/show/NCT00386802 |
Completed |
PETHEMA Foundation |
2008-12-31 |
| NCT00379964 |
A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00379964 |
Completed |
Merck Sharp & Dohme Corp. |
2006-05-31 |
| NCT00348985 |
PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00348985 |
Completed |
National Cancer Institute (NCI) |
2010-01-31 |
| NCT00336531 |
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00336531 |
Completed |
Samsung Medical Center |
2008-06-30 |
| NCT00326157 |
PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00326157 |
Completed |
Gilead Sciences |
2009-01-31 |
| NCT00300677 |
To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days |
https://ClinicalTrials.gov/show/NCT00300677 |
Completed |
Pfizer |
2008-08-31 |
| NCT00293345 |
3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00293345 |
Completed |
National Cancer Institute (NCI) |
2012-10-31 |
| NCT00292071 |
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) |
https://ClinicalTrials.gov/show/NCT00292071 |
Completed |
Merck Sharp & Dohme Corp. |
2006-07-31 |
| NCT00289991 |
Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) |
https://ClinicalTrials.gov/show/NCT00289991 |
Completed |
Pfizer |
2009-02-28 |
| NCT00288197 |
A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections |
https://ClinicalTrials.gov/show/NCT00288197 |
Completed |
Pfizer |
2007-06-30 |
| NCT00229060 |
Doripenem in the Treatment of Complicated Intra-Abdominal Infections |
https://ClinicalTrials.gov/show/NCT00229060 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00221039 |
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A |
https://ClinicalTrials.gov/show/NCT00221039 |
Completed |
M.D. Anderson Cancer Center |
2011-04-05 |
| NCT00210938 |
Doripenem in the Treatment of Complicated Intra-Abdominal Infections |
https://ClinicalTrials.gov/show/NCT00210938 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
NA |
| NCT00148148 |
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00148148 |
Completed |
University Hospital Muenster |
NA |
| NCT00185965 |
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas |
https://ClinicalTrials.gov/show/NCT00185965 |
Completed |
Stanford University |
2010-03-31 |
| NCT00178841 |
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL |
https://ClinicalTrials.gov/show/NCT00178841 |
Completed |
Vanderbilt University |
2007-03-31 |
| NCT00177710 |
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study |
https://ClinicalTrials.gov/show/NCT00177710 |
Completed |
University of Pittsburgh |
NA |
| NCT00177684 |
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) |
https://ClinicalTrials.gov/show/NCT00177684 |
Completed |
University of Pittsburgh |
NA |
| NCT00170430 |
Reducing Vaginal Infections in Women |
https://ClinicalTrials.gov/show/NCT00170430 |
Completed |
University of Washington |
2006-12-31 |
| NCT00168064 |
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT00168064 |
Completed |
Yaupon Therapeutics |
2010-08-31 |
| NCT00158730 |
Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment |
https://ClinicalTrials.gov/show/NCT00158730 |
Completed |
Gilead Sciences |
NA |
| NCT00150345 |
Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients |
https://ClinicalTrials.gov/show/NCT00150345 |
Completed |
Pfizer |
2009-04-30 |
| NCT00143312 |
Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants |
https://ClinicalTrials.gov/show/NCT00143312 |
Completed |
Pfizer |
2008-04-30 |
| NCT00136968 |
Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy |
https://ClinicalTrials.gov/show/NCT00136968 |
Completed |
Pfizer |
NA |
| NCT00118352 |
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00118352 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-07-31 |
| NCT00112593 |
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer |
https://ClinicalTrials.gov/show/NCT00112593 |
Completed |
Fred Hutchinson Cancer Research Center |
2014-11-30 |
| NCT00002479 |
Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome |
https://ClinicalTrials.gov/show/NCT00002479 |
Completed |
Northwestern University |
2002-08-31 |
| NCT00103246 |
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen’s Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT00103246 |
Completed |
Case Comprehensive Cancer Center |
2008-12-31 |
| NCT00098891 |
MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00098891 |
Completed |
National Cancer Institute (NCI) |
2008-03-31 |
| NCT00091559 |
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) |
https://ClinicalTrials.gov/show/NCT00091559 |
Completed |
Merck Sharp & Dohme Corp. |
2005-11-23 |
| NCT00003315 |
Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection |
https://ClinicalTrials.gov/show/NCT00003315 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00089271 |
17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00089271 |
Completed |
National Cancer Institute (NCI) |
2010-06-30 |
| NCT00089011 |
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00089011 |
Completed |
Fred Hutchinson Cancer Research Center |
2014-03-31 |
| NCT00003196 |
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT00003196 |
Completed |
Fred Hutchinson Cancer Research Center |
2002-04-30 |
| NCT00006251 |
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer |
https://ClinicalTrials.gov/show/NCT00006251 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-09-30 |
| NCT00074087 |
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT00074087 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2009-07-31 |
| NCT00005080 |
506U78 in Treating Patients With Lymphoma |
https://ClinicalTrials.gov/show/NCT00005080 |
Completed |
National Cancer Institute (NCI) |
2006-01-31 |
| NCT00005799 |
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer |
https://ClinicalTrials.gov/show/NCT00005799 |
Completed |
Fred Hutchinson Cancer Research Center |
2002-07-31 |
| NCT00078858 |
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00078858 |
Completed |
Fred Hutchinson Cancer Research Center |
2006-01-31 |
| NCT00075803 |
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) |
https://ClinicalTrials.gov/show/NCT00075803 |
Completed |
Medical College of Wisconsin |
2006-09-30 |
| NCT02306330 |
MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial |
https://ClinicalTrials.gov/show/NCT02306330 |
Completed |
Oxford University Clinical Research Unit, Vietnam |
2016-01-31 |
| NCT00072514 |
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies |
https://ClinicalTrials.gov/show/NCT00072514 |
Completed |
Fred Hutchinson Cancer Research Center |
2008-07-31 |
| NCT00003210 |
Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin’s Lymphoma or Hodgkin’s Disease |
https://ClinicalTrials.gov/show/NCT00003210 |
Completed |
National Cancer Institute (NCI) |
2003-11-30 |
| NCT00066664 |
Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin |
https://ClinicalTrials.gov/show/NCT00066664 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-12-31 |
| NCT00066599 |
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy |
https://ClinicalTrials.gov/show/NCT00066599 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00064311 |
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00064311 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00795769 |
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00795769 |
Completed |
Fred Hutchinson Cancer Research Center |
2009-06-09 |
| NCT00059878 |
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections |
https://ClinicalTrials.gov/show/NCT00059878 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00057967 |
Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome |
https://ClinicalTrials.gov/show/NCT00057967 |
Completed |
Northwestern University |
2007-06-26 |
| NCT00049504 |
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00049504 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-03-31 |
| NCT00047060 |
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome |
https://ClinicalTrials.gov/show/NCT00047060 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-01-24 |
| NCT00040846 |
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT00040846 |
Completed |
Fred Hutchinson Cancer Research Center |
2009-12-31 |
| NCT00025415 |
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT00025415 |
Completed |
National Cancer Institute (NCI) |
2005-01-31 |
| NCT00051012 |
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT00051012 |
Completed |
Eisai Inc. |
2006-10-31 |
| NCT00014235 |
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00014235 |
Completed |
Fred Hutchinson Cancer Research Center |
2005-02-28 |
| NCT00004241 |
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma |
https://ClinicalTrials.gov/show/NCT00004241 |
Completed |
National Cancer Institute (NCI) |
2006-05-31 |
| NCT00003970 |
Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00003970 |
Completed |
National Cancer Institute (NCI) |
2003-10-31 |
| NCT00038376 |
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies |
https://ClinicalTrials.gov/show/NCT00038376 |
Completed |
M.D. Anderson Cancer Center |
2005-06-30 |
| NCT00002687 |
Interleukin-2 in Treating Patients With Mycosis Fungoides |
https://ClinicalTrials.gov/show/NCT00002687 |
Completed |
University of Washington |
2003-07-31 |
| NCT00050999 |
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients |
https://ClinicalTrials.gov/show/NCT00050999 |
Completed |
Eisai Inc. |
2006-09-30 |
| NCT00005912 |
Voriconazole to Prevent Systemic Fungal Infections in Children |
https://ClinicalTrials.gov/show/NCT00005912 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001940 |
Voriconazole to Treat Fungal Infections |
https://ClinicalTrials.gov/show/NCT00001940 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001937 |
Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients |
https://ClinicalTrials.gov/show/NCT00001937 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001810 |
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT00001810 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001790 |
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia |
https://ClinicalTrials.gov/show/NCT00001790 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001757 |
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT00001757 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001280 |
Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease |
https://ClinicalTrials.gov/show/NCT00001280 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00034671 |
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) |
https://ClinicalTrials.gov/show/NCT00034671 |
Completed |
Merck Sharp & Dohme Corp. |
2001-11-30 |
| NCT00034658 |
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) |
https://ClinicalTrials.gov/show/NCT00034658 |
Completed |
Merck Sharp & Dohme Corp. |
2002-03-31 |
| NCT00034645 |
Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease |
https://ClinicalTrials.gov/show/NCT00034645 |
Completed |
Merck Sharp & Dohme Corp. |
2003-02-28 |
| NCT00034632 |
Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) |
https://ClinicalTrials.gov/show/NCT00034632 |
Completed |
Merck Sharp & Dohme Corp. |
2007-03-31 |
| NCT00033982 |
Posaconazole to Treat Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT00033982 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00005668 |
A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma |
https://ClinicalTrials.gov/show/NCT00005668 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00002325 |
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common |
https://ClinicalTrials.gov/show/NCT00002325 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002277 |
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections |
https://ClinicalTrials.gov/show/NCT00002277 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00817765 |
Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir |
https://ClinicalTrials.gov/show/NCT00817765 |
Completed |
Radboud University |
2009-07-31 |
| NCT00002122 |
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients |
https://ClinicalTrials.gov/show/NCT00002122 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002038 |
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy |
https://ClinicalTrials.gov/show/NCT00002038 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001107 |
Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants |
https://ClinicalTrials.gov/show/NCT00001107 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000826 |
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites |
https://ClinicalTrials.gov/show/NCT00000826 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000676 |
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) |
https://ClinicalTrials.gov/show/NCT00000676 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00408681 |
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00408681 |
Completed |
Fred Hutchinson Cancer Research Center |
2010-11-30 |
| NCT00015665 |
Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT00015665 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |